Intra-Cellular Therapies Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Nov 23 | Sell€801,048 | Mark Neumann | Individual | 15,639 | €51.22 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 19,628 | 0.0186% |
Individual Insiders | 2,214,227 | 2.1% |
General Public | 6,700,490 | 6.36% |
Institutions | 96,420,186 | 91.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,452,357 | €784.3m | 4.36% | 0.06% | |||
9,094,302 | €622.8m | 6.49% | 0.01% | |||
8,193,544 | €561.1m | 9.03% | 0.01% | |||
4,743,770 | €324.9m | 0% | 100.0% | |||
3,854,747 | €264.0m | 6.27% | 1.06% | |||
3,066,400 | €210.0m | -3.28% | 2.51% | |||
2,255,555 | €154.5m | 0% | 2.41% | |||
2,220,850 | €152.1m | 4% | 0.01% | |||
2,001,791 | €137.1m | 4.75% | 0.01% | |||
2,000,000 | €137.0m | -23.1% | 5.12% | |||
1,918,430 | €131.4m | -2.91% | 0.02% | |||
1,818,046 | €124.5m | 0.62% | 0.04% | |||
1,802,027 | €123.4m | -4.85% | 0.04% | |||
1,767,184 | €121.0m | -0.56% | 0.05% | |||
1,763,475 | €120.8m | -2.89% | 0.02% | |||
1,628,244 | €111.5m | -3.77% | 1.06% | |||
1,564,153 | €107.1m | 14.4% | 0.13% | |||
1,553,135 | €106.4m | 10.7% | 0.09% | |||
1,334,743 | €91.4m | -23.6% | 0.07% | |||
1,261,857 | €86.4m | -11.9% | 0.34% | |||
1,260,897 | €86.4m | 92% | 0.01% | |||
1,197,203 | €82.0m | 14.9% | 0.01% | |||
1,165,948 | €79.8m | -14.9% | 3.7% | |||
1,070,329 | €73.3m | 1.91% | no data | |||
1,039,821 | €71.2m | 33.5% | 0.01% |